Matches in SemOpenAlex for { <https://semopenalex.org/work/W3189503588> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3189503588 endingPage "4" @default.
- W3189503588 startingPage "1" @default.
- W3189503588 abstract "Background: An equivalent efficacy compared with racemic amlodipine with reduced or insignificant peripheral edema makes S-amlodipine a costeffective treatment alternative in hypertension. S-amlodipine has also been proven to be effective, safe, and well-tolerated even when used as combination therapy with other antihypertensive agents. S-amlodipine has added benefits in optimizing atherogenic lipids and reduces cardiovascular outcomes. The present review was performed to assess the health economics of the use of S-amlodipine in hypertension.Methods: Authors conducted a systematic review of published literature to evaluate the health economics and outcomes research of the use of S-amlodipine in hypertension treatment. The Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were used to report this review.Results and discussion: The authors finalized a total of 34 articles, including randomized clinical trials, systematic review, and metaanalysis. The authors discuss the health care cost benefits associated with managing hypertension, use of amlodipine and its cost efficacy in managing hypertension, the significance of S-amlodipine in terms of equivalence of antihypertensive efficacy reduced side effects, and better cost implications.Conclusion: The authors concluded that S-amlodipine in hypertension treatment is not only cost-effective, but it also reduces the risk of peripheral edema when compared with racemic amlodipine.Key points for clinicians• It is economically viable to treat patients with diastolic blood pressure more than or equal to 90 mm Hg, except those below 45 years of age.• Amlodipine is a cost-saving therapy compared with angiotensin receptor II blockers in preventing stroke, myocardial infarction in hypertension patients.• S-amlodipine has equivalent antihypertensive activity, with a significantly reduced risk of peripheral oedema compared with racemic amlodipine.• Use of S-amlodipine is cost effective and can save health care expenditure compared with standard care." @default.
- W3189503588 created "2021-08-16" @default.
- W3189503588 creator A5009999150 @default.
- W3189503588 creator A5029247107 @default.
- W3189503588 creator A5032897026 @default.
- W3189503588 creator A5044901731 @default.
- W3189503588 creator A5051073256 @default.
- W3189503588 date "2021-01-01" @default.
- W3189503588 modified "2023-09-23" @default.
- W3189503588 title "Cost efficacy of S-Amlodipine vs Racemic Amlodipine in Hypertension Management" @default.
- W3189503588 doi "https://doi.org/10.35248/2471-268x.21.7.177" @default.
- W3189503588 hasPublicationYear "2021" @default.
- W3189503588 type Work @default.
- W3189503588 sameAs 3189503588 @default.
- W3189503588 citedByCount "0" @default.
- W3189503588 crossrefType "journal-article" @default.
- W3189503588 hasAuthorship W3189503588A5009999150 @default.
- W3189503588 hasAuthorship W3189503588A5029247107 @default.
- W3189503588 hasAuthorship W3189503588A5032897026 @default.
- W3189503588 hasAuthorship W3189503588A5044901731 @default.
- W3189503588 hasAuthorship W3189503588A5051073256 @default.
- W3189503588 hasConcept C126322002 @default.
- W3189503588 hasConcept C168563851 @default.
- W3189503588 hasConcept C177713679 @default.
- W3189503588 hasConcept C197934379 @default.
- W3189503588 hasConcept C2777482430 @default.
- W3189503588 hasConcept C2779646130 @default.
- W3189503588 hasConcept C500558357 @default.
- W3189503588 hasConcept C535046627 @default.
- W3189503588 hasConcept C71924100 @default.
- W3189503588 hasConcept C84393581 @default.
- W3189503588 hasConceptScore W3189503588C126322002 @default.
- W3189503588 hasConceptScore W3189503588C168563851 @default.
- W3189503588 hasConceptScore W3189503588C177713679 @default.
- W3189503588 hasConceptScore W3189503588C197934379 @default.
- W3189503588 hasConceptScore W3189503588C2777482430 @default.
- W3189503588 hasConceptScore W3189503588C2779646130 @default.
- W3189503588 hasConceptScore W3189503588C500558357 @default.
- W3189503588 hasConceptScore W3189503588C535046627 @default.
- W3189503588 hasConceptScore W3189503588C71924100 @default.
- W3189503588 hasConceptScore W3189503588C84393581 @default.
- W3189503588 hasIssue "7" @default.
- W3189503588 hasLocation W31895035881 @default.
- W3189503588 hasOpenAccess W3189503588 @default.
- W3189503588 hasPrimaryLocation W31895035881 @default.
- W3189503588 hasRelatedWork W190331528 @default.
- W3189503588 hasRelatedWork W1911563699 @default.
- W3189503588 hasRelatedWork W1985325533 @default.
- W3189503588 hasRelatedWork W2063517383 @default.
- W3189503588 hasRelatedWork W2064466834 @default.
- W3189503588 hasRelatedWork W2067405284 @default.
- W3189503588 hasRelatedWork W2095622909 @default.
- W3189503588 hasRelatedWork W2169493364 @default.
- W3189503588 hasRelatedWork W2184735713 @default.
- W3189503588 hasRelatedWork W2275127901 @default.
- W3189503588 hasRelatedWork W2393513591 @default.
- W3189503588 hasRelatedWork W2417548254 @default.
- W3189503588 hasRelatedWork W2418173203 @default.
- W3189503588 hasRelatedWork W2641950914 @default.
- W3189503588 hasRelatedWork W2898773360 @default.
- W3189503588 hasRelatedWork W2992111795 @default.
- W3189503588 hasRelatedWork W3036119577 @default.
- W3189503588 hasRelatedWork W3036228940 @default.
- W3189503588 hasRelatedWork W3204149036 @default.
- W3189503588 hasRelatedWork W582799793 @default.
- W3189503588 hasVolume "7" @default.
- W3189503588 isParatext "false" @default.
- W3189503588 isRetracted "false" @default.
- W3189503588 magId "3189503588" @default.
- W3189503588 workType "article" @default.